Early Recanalization in Patients With Cerebral Venous Thrombosis Treated With Anticoagulation

• Type: Article in International Scientific Journal
• Date: 2020

Authors

de Sousa, DA (Author) Other; Neto, LL (Author) Other; Arauz, A (Author) Other; Sousa, AL (Author) Other; Gabriel, D (Author) Other; Correia, M (Author) Other; Gil Gouveia, R (Author) Other; Penas, S (Author) Other; Dias, MC (Author) Other; Correia, MA (Author) Other; Marta Carvalho (Author) FMUP; Canhao, P (Author) Other; Ferro, JM (Author) Other

Journal

Title: Stroke

Vol. 51

Pages: 1174-1181

ISSN: 0039-2499

Publisher: Wolters Kluwer Health

Indexing

ISI Web of Knowledge - 34 Citations

Scopus - 37 Citations

Other information

Authenticus ID: P-00S-15H

DOI: 10.1161/strokeaha.119.028532

Abstract (EN): Background and Purpose-The hypothesis that venous recanalization prevents progression of venous infarction is not established in patients with cerebral venous thrombosis (CVT). Evidence is also scarce on the association between residual symptoms, particularly headache, and the recanalization grade. We aimed to assess, in patients with CVT treated with standard anticoagulation, (1) the rate of early venous recanalization, (2) whether lack of early recanalization was predictor of parenchymal brain lesion progression, and (3) the prevalence and features of persistent headache according to the recanalization grade achieved. Methods-PRIORITy-CVT (Pathophysiology of Venous Infarction - Prediction of Infarction and Recanalization in CVT) was a multicenter, prospective, cohort study including patients with newly diagnosed CVT. Standardized magnetic resonance imaging was performed at inclusion (<= 24 hours of therapeutic anticoagulation), days 8 and 90. Potential imaging predictors of recanalization were predefined and analyzed at each anatomical segment. Primary outcomes were rate of early recanalization and brain lesion progression at day 8. Secondary outcomes were headache (days 8 and 90) and functional outcome (modified Rankin Scale at days 8 and 90). Results-Sixty eight patients with CVT were included, of whom 30 (44%) had parenchymal lesions. At the early follow-up (n=63; 8 +/- 2 days), 68% (n=43) of patients had partial recanalization and 6% (n=4) full recanalization. Early recanalization was associated both with early regression (P=0.03) and lower risk of enlargement of nonhemorrhagic lesions (P=0.02). Lesions showing diffusion restriction (n=12) were fully reversible in 66% of cases, particularly in patients showing early venous recanalization. Evidence of new or enlarged hemorrhagic lesions, headache at days 8 and 90, and unfavorable functional outcome at days 8 and 90 were not significantly different in patients achieving recanalization. Conclusions-Venous recanalization started within the first 8 days of therapeutic anticoagulation in most patients with CVT and was associated with early regression of nonhemorrhagic lesions, including venous infarction. There was an association between persistent venous occlusion at day 8 and enlargement of nonhemorrhagic lesions.

Language: English

Type (Professor's evaluation): Dissemination

No. of pages: 8